ROCHELLE, Va., Nov. 7, 2018 /PRNewswire-PRWeb/ -- NDA Partners Chairman Carl Peck, MD,
Prior to joining NDA Partners, Ms. Geiger was the Executive Vice President of Clinical Development and Head of Global Oncology at Clinipace Inc., where she was responsible for providing direct oversight and strategy for the Clinical Operations Division in the US, Australia, and Latin America and for managing clinical operations interactions with the European division. She was the founder of Worldwide Clinical Research, Inc. and served as President until its acquisition by Clinipace Worldwide. She was formerly Director of Corporate Partnerships, Director of Business Development, Director of Operations, and Director of Project Management at PRA International. Early in her career, she served as the Assistant Director of Clinical Monitoring at ClinTrials, Inc. and a Clinical Scientist and Senior CRA at Marion Laboratories, Marion Merrell Dow, Inc.
According to Dr. Carl Peck, NDA Partners' Chairman, "Ms. Geiger's extensive experience in global clinical trial management, including managing operations and trials focused on oncology and CNS development, will be a valuable resource for our clients who are designing and conducting clinical trials worldwide. We are very pleased that she has joined NDA Partners' team of Expert Consultants."
Ms. Geiger earned a Bachelor of Science degree in nursing from the University of Kansas and was a graduate of Columbia University's Senior Executive Program. She is a Registered Nurse having worked in the clinic in pediatric oncology and as an outpatient research coordinator. She is a member of the American Society of Clinical Oncology (ASCO) and the Drug Information Association (DIA).
About NDA Partners NDA Partners is a life sciences management consulting and contract development organization (CDO) focused on providing product development and regulatory services to the pharmaceutical, biotechnology, and medical device industries worldwide. The highly experienced Principals and Premier Experts of NDA Partners include three former FDA Center Directors; the former Chairman of the Medicines and Healthcare Products Regulatory Agency (MHRA) in the UK; an international team of more than 100 former pharmaceutical industry and regulatory agency senior executives; and an extensive roster of highly proficient experts in specialized areas including nonclinical development, toxicology, pharmacokinetics, CMC, medical device design control and quality systems, clinical development, regulatory submissions, and development program management. Services include product development and regulatory strategy, expert consulting, high-impact project teams, and contract management of client product development programs.
Contact Earle Martin, Chief Executive Officer Office: 540-738-2550 MartinEarle@ndapartners.com
SOURCE NDA Partners, LLC
Subscribe to our Free Newsletters!